z-logo
open-access-imgOpen Access
CCL2 Inhibits the Apoptosis Program Induced by Growth Factor Deprivation, Rescuing Functional T Cells
Author(s) -
Eva DíazGuerra,
Rolando Vernal,
Michela Prete,
Augusto Silva,
José A. GarcíaSanz
Publication year - 2007
Publication title -
the journal of immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.737
H-Index - 372
eISSN - 1550-6606
pISSN - 0022-1767
DOI - 10.4049/jimmunol.179.11.7352
Subject(s) - microbiology and biotechnology , apoptosis , chemokine , cd8 , cytotoxic t cell , ccr2 , biology , ccl2 , cytokine , t cell , chemokine receptor , immunology , chemistry , antigen , immune system , biochemistry , in vitro
The precise mechanisms involved in the switch between the clonal expansion and contraction phases of a CD8(+) T cell response remain to be fully elucidated. One of the mechanisms implicated in the contraction phase is cytokine deprivation, which triggers apoptosis in these cells. CCR2 chemokine receptor is up-regulated following IL-2 deprivation, and its ligand CCL2 plays an essential role preventing apoptosis induced by IL-2 withdrawal not only in CTLL2 cells, but also in mouse Ag-activated primary CD8(+) T cells because it rescued functional CD8(+) T cells from deprivation induced apoptosis, promoting proliferation in response to subsequent addition of IL-2 or to secondary antigenic challenges. Thus, up-regulation of the CCR2 upon growth factor withdrawal together with the protective effects of CCL2, represent a double-edged survival strategy, protecting cells from apoptosis and enabling them to migrate toward sites where Ag and/or growth factors are available.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom